HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark S Shearman Selected Research

Mark S Shearman Research Topics

Disease

25Alzheimer Disease (Alzheimer's Disease)
09/2015 - 07/2002
4Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2020 - 01/2017
2Atrophy
01/2020 - 01/2017
1Inflammation (Inflammations)
01/2020
1Toxic Optic Neuropathy
01/2020
1Hyperemia
01/2017
1Photophobia (Light Sensitivity)
01/2017
1Color Vision Defects (Color Blindness)
01/2017
1Hemorrhage
01/2017
1Tauopathies
04/2014
1Amyloid Plaque
02/2007
1Neoplasms (Cancer)
02/2007
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2007
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
02/2007
1Neuroblastoma
12/2004
1Amyloidosis
10/2004

Drug/Important Bio-Agent (IBA)

14Amyloid beta-PeptidesIBA
05/2010 - 08/2002
11Amyloid Precursor Protein Secretases (beta-Secretase)IBA
09/2015 - 11/2002
9Peptides (Polypeptides)IBA
04/2010 - 11/2002
6Proteins (Proteins, Gene)FDA Link
01/2020 - 07/2002
5Gamma Secretase Inhibitors and ModulatorsIBA
04/2010 - 06/2003
4Amyloid (Amyloid Fibrils)IBA
01/2015 - 07/2002
3GTP Phosphohydrolases (GTPases)IBA
01/2020 - 12/2018
3N- (4- azidobenzoylglycyl)- S- (2- thiopyridyl)cysteine (AGTC)IBA
01/2020 - 01/2017
3Retinaldehyde (Retinal)IBA
01/2020 - 01/2017
2Peptide Hydrolases (Proteases)FDA Link
01/2006 - 11/2002
1CytokinesIBA
01/2020
1Codon (Codons)IBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Neutralizing AntibodiesIBA
01/2020
1AmidesIBA
09/2015
1hexosaminidase CIBA
04/2014
1PurinesIBA
04/2010
1PyrimidinesIBA
02/2010
1Hydroxyl RadicalIBA
04/2009
1MetalsIBA
04/2009
1Protein Isoforms (Isoforms)IBA
04/2009
1amyloid beta-protein (1-42)IBA
04/2009
1EnzymesIBA
02/2007
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2006
1Flurbiprofen (Froben)FDA LinkGeneric
04/2006
1PresenilinsIBA
12/2004
1Presenilin-1IBA
12/2004
1Flavin-Adenine Dinucleotide (FAD)IBA
10/2004
1BenzodiazepinesIBA
06/2003
1Aspartic Acid ProteasesIBA
07/2002
1Cathepsin DIBA
07/2002

Therapy/Procedure

3Therapeutics
04/2009 - 11/2002
1Lasers (Laser)
10/2004